Neurology
Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}
      • decorative

      Patient Cases

      Duodopa logo

      Patient Cases

      Duodopa
      Clinical Profile
      Duodopa Treatment
      Patient Cases
      Expert Insights
      Resources
      Training & e-Learning

      Real-life Duodopa Case Study Series

      This case study series introduces key considerations in the management of advanced Parkinson’s disease (aPD) through a series of case study learnings and expert focus on individual patient scenarios.

      Download the case study series to learn how real-life scenarios of people with Parkinson’s disease (PD) were managed with Duodopa (levodopa/carbidopa intestinal gel).

      Resources guide for hospitals

      Case submitted
      by Dr Raju George

      69-year-old male patient

      presenting with progressing PD. The patient’s ON-time and OFF-time had narrowed to 1 hour and he was taking levodopa/benserazide 5 times a day. His movement was severely restricted and required the use of a walking stick.

      READ MORE
      Resources guide for hospitals

      Case submitted
      by Dr Raju George

      Male patient in his 80’s

      presenting with aPD. The patient had mobility issues, dysphagia, which made it difficult to administer his medication, was losing his voice, had reduced ON-time of 2 hours, and was taking levodopa/carbidopa 6 times a day.

      READ MORE
      Resources guide for hospitals

      Case submitted by Dr Christina
      Liang and Sue Williams

      82-year-old female patient

      presenting aPD symptoms of dyskinesia during ON-time, sudden and unpredictable OFF-times, who was taking 5 oral levodopa tablets daily.

      READ MORE
      Dr Andrew Evans

      Case submitted
      by Dr Andrew Evans

      69-year-old male patient

      presenting with aPD, taking oral levodopa/carbidopa 5 times a day, had 2 hours ON-time, severe OFF-time, reduced mobility and disabling dyskinesia.

      READ MORE
      Resources guide for hospitals

      Case submitted
      by Dr Matt Lee-Archer

      70-year-old female patient

      presenting with aPD, evident due to her dyskinesia, reduced ON-time of 3–4 hours, sudden and unpredictable OFF-times, and administration of levodopa 6 times a day.

      READ MORE
      Contact a representative
      Contact a representative

      PBS Information

      DUODOPA: Authority required (STREAMLINED): S100 HSD Public, S100 HSD Private and S85 General Schedule. Refer to Pharmaceutical Benefits Scheme for full authority information.

      Please review the full Product Information (PI) before prescribing, available below.

      DUODOPA PI

      Duodopa is indicated for the treatment of advanced idiopathic Parkinson’s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.1

      Abbreviation: aPD, Advanced Parkinson’s disease, PD, Parkinson’s disease.
      References: 1. Duodopa Australian Product Information.

      AU-DUOD-230120. June 2024.